Vincent Lo Re III, MD, MSCE

Vincent Lo Re III, MD, MSCE

University of Pennsylvania

H-index: 45

North America-United States

About Vincent Lo Re III, MD, MSCE

Vincent Lo Re III, MD, MSCE, With an exceptional h-index of 45 and a recent h-index of 31 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Viral hepatitis, HIV/viral hepatitis coinfection, pharmacoepidemiology, drug-induced liver injury.

His recent articles reflect a diverse array of research interests and contributions to the field:

Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States

Core concepts in pharmacoepidemiology: validation of health outcomes of interest within real‐world healthcare databases

Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy

Pharmacoepidemiology and Drug Safety’s Core Concepts in Pharmacoepidemiology Section at One Year: Where Do We Go from Here?

Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States

Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016

Mo1540 RISK FACTORS FOR HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG HIV/HBV-COINFECTED ADULTS IN CARE IN THE UNITED STATES

Oral health outcomes in an HIV cohort with comorbidities-implementation roadmap for a longitudinal prospective observational study

Vincent Lo Re III, MD, MSCE Information

University

Position

Associate Professor of Medicine & Epidemiology

Citations(all)

7568

Citations(since 2020)

4236

Cited By

5480

hIndex(all)

45

hIndex(since 2020)

31

i10Index(all)

127

i10Index(since 2020)

88

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

Vincent Lo Re III, MD, MSCE Skills & Research Interests

Viral hepatitis

HIV/viral hepatitis coinfection

pharmacoepidemiology

drug-induced liver injury

Top articles of Vincent Lo Re III, MD, MSCE

Title

Journal

Author(s)

Publication Date

Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States

Clinical Epidemiology

Vincent Lo Re III

Noelle M Cocoros

Rebecca A Hubbard

Sarah K Dutcher

Craig W Newcomb

...

2024/12/31

Core concepts in pharmacoepidemiology: validation of health outcomes of interest within real‐world healthcare databases

Erica J Weinstein

Mary Elizabeth Ritchey

Vincent Lo Re III

2023/1

Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy

JAMA network open

Emily J Cartwright

Chloe Pierret

Caroline Minassian

Denise A Esserman

Janet P Tate

...

2023/9/5

Pharmacoepidemiology and Drug Safety’s Core Concepts in Pharmacoepidemiology Section at One Year: Where Do We Go from Here?

Authorea Preprints

Jennifer Lund

Vincent Lo Re

2023/5/24

Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States

Journal of viral hepatitis

Nicole D Ferrante

Michael J Kallan

Sophia Sukkestad

Maja Kodani

Mari M Kitahata

...

2023/11

Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016

Plos one

Jessica Kim

Craig W Newcomb

Dena M Carbonari

Jessie Torgersen

Keri N Althoff

...

2023/9/1

Mo1540 RISK FACTORS FOR HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG HIV/HBV-COINFECTED ADULTS IN CARE IN THE UNITED STATES

Gastroenterology

Nicole Ferrante

Michael Kallan

Sophia M Sukkestad

Maja Kodani

Mari M Kitahata

...

2023/5/1

Oral health outcomes in an HIV cohort with comorbidities-implementation roadmap for a longitudinal prospective observational study

BMC Oral Health

Temitope T Omolehinwa

Sunday O Akintoye

Marta Gabinskiy

Vincent Lo Re III

Mel Mupparapu

...

2023/10/17

Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012–2019

American journal of public health

Laura Hawks

Emily A Wang

Adeel A Butt

Stephen Crystal

D Keith McInnes

...

2023/2

Disentangling the postacute sequelae of SARS-CoV-2: E unibus pluram (from one, many)

JAMA

Robert Gross

Vincent Lo Re

2023/6/13

Incidence, microbiological studies, and factors associated with prosthetic joint infection after total knee arthroplasty

JAMA Network Open

Erica J Weinstein

Alisa J Stephens-Shields

Craig W Newcomb

Randi Silibovsky

Charles L Nelson

...

2023/10/2

Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases–infectious diseases society of America recommendations for testing, managing, and …

Clinical Infectious Diseases

Debika Bhattacharya

Andrew Aronsohn

Jennifer Price

Vincent Lo Re

Jon Heald

...

2023

Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States

Pharmacoepidemiology and drug safety

Wei Wang

Chao Chen

Vincent Lo Re III

Shao‐Hsuan Chang

Debbie L Wilson

...

2023/10

Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications

Journal of the American Geriatrics Society

Kathleen M Akgün

Supriya Krishnan

Janet Tate

Kendall Bryant

Margaret A Pisani

...

2023/6

Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective …

BMJ medicine

Vincent Lo Re III

Sarah K Dutcher

John G Connolly

Silvia Perez-Vilar

Dena M Carbonari

...

2023

Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV

Pharmacoepidemiology and Drug Safety

Jessie Torgersen

Scott Akers

Yuankai Huo

James G Terry

J Jeffrey Carr

...

2023/10

Hepatitis C Guidance 2023 Update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection

Debika Bhattacharya

Andrew Aronsohn

Jennifer Price

Vincent Lo Re III

2023/5/25

1313. Determinants of Prosthetic Joint Infection According to Time Following Total Knee Arthroplasty: A Retrospective Cohort Study Among US Veterans

Open Forum Infectious Diseases

Erica J Weinstein

Vincent Lo Re

Alisa Stephens-Shields

Craig Newcomb

Randi Silibovsky

...

2023/12

Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products

Pharmacoepidemiology and Drug Safety

Cynthia J Girman

Mary E Ritchey

Vincent Lo Re III

2022/7

The hepatitis C care cascade during the direct-acting antiviral era in a United States commercially insured population

Open forum infectious diseases

Nicole D Ferrante

Craig W Newcomb

Kimberly A Forde

Charles E Leonard

Jessie Torgersen

...

2022/9/1

See List of Professors in Vincent Lo Re III, MD, MSCE University(University of Pennsylvania)